Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities-Reference-Cited by-同舟云学术

Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities

Published:2022-04-21 Issue:7 Volume:57 Page:1144-1153
ISSN:1082-6084
Container-title:Substance Use & Misuse
language:en
Short-container-title:Substance Use & Misuse

Author:

Walters Suzan M.¹²^ORCID,Perlman David C.²³,Guarino Honoria²⁴,Mateu-Gelabert Pedro²⁴,Frank David¹²^ORCID

Affiliation:

1. School of Global Public Health, New York University, New York, New York, USA;

2. Center for Drug Use and HIV/HCV Research, NYU School of Global Public Health, New York, New York, USA;

3. Icahn School of Medicine at Mount Sinai, New York, New York, USA;

4. Graduate School of Public Health & Health Policy, City University of New York, New York, New York, USA

Funder

National Institute on Drug Abuse

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous),Health (social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826084.2022.2064509

Reference89 articles.

1. COVID-19 risks among people who inject drugs in Puerto Rico

2. Power & Community

3. The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era

4. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

5. What is Qualitative in Qualitative Research

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment;Journal of Addiction Medicine;2024-08-05

2. New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review;Journal of Drug Issues;2024-08-02

3. Identifying facilitators and barriers to the uptake of medication for opioid use disorder in Washington, DC: A community-engaged concept mapping approach;PLOS ONE;2024-07-19

4. “If it wasn’t for them, I don’t think I would be here”: experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis;Harm Reduction Journal;2024-06-07

5. The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine;Addiction;2024-05-28